Skip to content
healthcare.dev

chlorothiazide sodium

NDC 25021-305, chlorothiazide sodium, injection, powder, lyophilized, for solution, from Sagent Pharmaceuticals.

Product NDC
25021-305
Status
Listed
Labeler
Sagent Pharmaceuticals
Dosage form
INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Route
INTRAVENOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA202462
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/25021-305 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • CHLOROTHIAZIDE SODIUM500 mg/18mL

Pharmacologic classes

Increased Diuresis [PE]; Thiazide Diuretic [EPC]; Thiazides [CS]

Package NDCNDC-11Package
25021-305-20250210305201 VIAL in 1 CARTON (25021-305-20) / 18 mL in 1 VIAL
25021-305-66250210305661 VIAL in 1 CARTON (25021-305-66) / 18 mL in 1 VIAL

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels?ndc=25021-305
  • Medicare Part B payment limits (ASP)

    GET /v1/drugs/asp?ndc=25021-305

Use it

Look up 25021-305 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/25021-305 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 25021-305. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.